Morgan Stanley
BCTX

Morgan Stanley’s Briacell Therapeutics BCTX Stock Holding History

Morgan Stanley’s Portfolio BCTX Stock Details BCTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.7K Sell
3,021
-480
-14% -$2.23K ﹤0.01% 6880
2025
Q4 		$24.9K Buy
3,501
+3,387
+2,971% +$35.7K ﹤0.01% 6623
2025
Q3 		$1.25K Buy
114
+113
+11,300% +$1.19K ﹤0.01% 7372
2025
Q2 		$38 Sell
1
-58
-98% -$2.11K ﹤0.01% 7865
2025
Q1 		$2.16K Buy
59
+48
+436% +$2.29K ﹤0.01% 7160
2024
Q4 		$937 Sell
11
-7
-39% -$839 ﹤0.01% 7283
2024
Q3 		$3.3K Hold
18
– – ﹤0.01% 7021
2024
Q2 		$3.03K Sell
18
-140
-89% -$39.6K ﹤0.01% 6979
2024
Q1 		$67.7K Sell
158
-706
-82% -$389K ﹤0.01% 6121
2023
Q4 		$758K Buy
864
+231
+36% +$166K ﹤0.01% 5433
2023
Q3 		$594K Buy
633
+131
+26% +$128K ﹤0.01% 5091
2023
Q2 		$483K Buy
502
+30
+6% +$29.6K ﹤0.01% 5231
2023
Q1 		$527K Buy
472
+446
+1,715% +$462K ﹤0.01% 5223
2022
Q4 		$17.1K Buy
26
+6
+30% +$5.08K ﹤0.01% 6745
2022
Q3 		$17K Buy
20
+1
+5% +$1K ﹤0.01% 6849
2022
Q2 		$16K Sell
19
-116
-86% -$115K ﹤0.01% 7062
2022
Q1 		$206K Buy
135
+80
+145% +$94.7K ﹤0.01% 5910
2021
Q4 		$68K Buy
55
+7
+15% +$9.17K ﹤0.01% 6651
2021
Q3 		$59K Sell
48
-74
-61% -$68K ﹤0.01% 6640
2021
Q2 		$97K Buy
+122
New +$76K ﹤0.01% 6373

Other funds holding BCTX

CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
LCM
LuminArx Capital Management New York $136M AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
AF
Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Morgan Stanley's BCTX Position: Q1 2026 in Review

Morgan Stanley reduced its Briacell Therapeutics (BCTX) stake by 14% in Q1 2026, selling an estimated $2.23K and leaving 3,021 shares worth $12.7K. The position accounts for ﹤0.01% of the portfolio, ranked #6880.

Morgan Stanley first reported a position in BCTX in Q2 2021 and has held it in 20 quarters since. The position peaked at $758K in Q4 2023. 16 funds tracked by Wall St. Rank hold BCTX as of Q1 2026.

  • Morgan Stanley held 3,021 shares of Briacell Therapeutics worth $12.7K as of Q1 2026.
  • Morgan Stanley sold 480 Briacell Therapeutics shares in Q1 2026, an estimated $2.23K.
  • Briacell Therapeutics made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #6880 holding.
  • Morgan Stanley first reported a position in Briacell Therapeutics in Q2 2021 and has held it in 20 quarters since.
  • Morgan Stanley's Briacell Therapeutics position peaked at $758K in Q4 2023.
  • 16 funds tracked by Wall St. Rank held Briacell Therapeutics as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.